Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Tel Aviv
- Most recent report
- 10-Q, filed Nov 3, 2026
- Incorporated
- N/A
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 818686
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 51
News 8 of 94
Prospectuses and Registrations 8 of 29
- 25-NSE Notice that a security was delisted Sep 14, 2026
- 424B5 Prospectus supplement for an offering Sep 11, 2026
- FWP Free writing prospectus Sep 10, 2026
- FWP Free writing prospectus Sep 10, 2026
- 424B5 Prospectus supplement for an offering Sep 8, 2026
- 424B5 Prospectus supplement for an offering May 22, 2025
- FWP Free writing prospectus May 20, 2025
- 424B5 Prospectus supplement for an offering May 19, 2025
Proxies 8 of 22
- DEFA14A Extra proxy material Mar 31, 2026
- DEF 14A Proxy statement for a shareholder vote Mar 31, 2026
- DEFA14A Extra proxy material Apr 9, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 9, 2025
- DEFA14A Extra proxy material Apr 16, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 16, 2024
- DEFA14A Extra proxy material May 24, 2023
- DEFA14A Extra proxy material Apr 19, 2023
Ownership 8 of 758
- 144 Notice of a proposed sale of restricted stock Nov 9, 2026
- 4 Insider reported a trade Nov 6, 2026
- 4 Insider reported a trade Nov 6, 2026
- 144 Notice of a proposed sale of restricted stock Nov 5, 2026
- 144 Notice of a proposed sale of restricted stock Nov 4, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 2, 2026
- 3 Insider reported their initial holding Oct 8, 2026
- 4 Insider reported a trade Sep 22, 2026
Other 8 of 47
- 8-A12B/A Registration of a security for exchange listing, amended Sep 14, 2026
- F-6 POS Jul 29, 2026
- ARS Annual report sent to shareholders Mar 31, 2026
- SD Conflict minerals disclosure Jun 2, 2025
- UPLOAD Comment letter from SEC staff Apr 28, 2025
- CORRESP Reply to SEC staff Apr 14, 2025
- ARS Annual report sent to shareholders Apr 9, 2025
- UPLOAD Comment letter from SEC staff Apr 7, 2025
Everything here comes from Teva Pharmaceutical Industries Ltd's own filings on SEC EDGAR. The filing list is rechecked every hour.